An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease.

Trial Profile

An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Nov 2014

At a glance

  • Drugs Levodopa/carbidopa (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Intec Pharma
  • Most Recent Events

    • 03 Feb 2012 Status changed from recruiting to completed, as reported in an Intec Pharma media release.
    • 04 Feb 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 03 Feb 2010 Primary endpoint 'Drug-concentration' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top